electroCore to Present at the Market Movers Investor Summit on May 5, 2026
electroCore (Nasdaq: ECOR) announced it will present at the Market Movers Investor Summit on May 5, 2026.
Rhea-AI Summary
electroCore (Nasdaq: ECOR) announced it will present at the Market Movers Investor Summit on May 5, 2026. Joshua Lev, Interim President and CFO, will deliver a company presentation at 12:20 PM ET and hold one-on-one meetings at the Bank of New York, 48 Wall Street, New York.
Requests for invitations are available at www.marketmoverssummit.com. The summit features presentations, fireside chats, one-on-ones, and networking across May 4–5, 2026.
Positive
- None.
Negative
- None.
Details
News Market Reaction – ECOR
In the Apr 28 session, ECOR gained 1.32%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- 2025 net sales
- $32.0 million
- Year ended Dec 31, 2025 net sales from 8-K filing
- Revenue growth
- 27%
- 2025 net sales growth versus 2024 from 8-K filing
- Gross profit & margin
- $27.8 million, 87%
- 2025 gross profit and margin improvement from 85% in 8-K
- Operating expenses
- $40.9 million
- 2025 operating expenses from 8-K filing
- GAAP net loss
- $14.0 million
- 2025 GAAP net loss, $1.65 per share from 8-K
- Adjusted EBITDA net loss
- $8.7 million
- 2025 adjusted EBITDA net loss from 8-K
- Cash & equivalents
- $11.6 million
- Total cash, cash equivalents, and marketable securities at 2025 year-end
- 2026 revenue guidance
- 30% annual growth
- 2026 revenue growth outlook from 8-K filing
Historical Context
-
Documentary highlighted electroCore’s nVNS products and expanding clinical and consumer use.
-
Announcement of participation and one-on-one meetings at Needham healthcare conference.
-
First patients enrolled in investigator-led PTSD study using gammaCore nVNS device.
-
Frontiers in Neuroscience paper showed symptom reduction with nVNS in mTBI and PTSD.
-
Executive hires and RSU grants under NASDAQ inducement rule for new leadership.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ROCKAWAY, N.J., April 28, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers Investor Summit at the historic Bank of New York. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.
Event Details:
- Date: Tuesday, May 5, 2026
- Company Presentation: 12:20 PM ET
- Location: 48 Wall Street, New York, NY (The original Bank of New York)
Request an invitation to attend at www.marketmoverssummit.com.
Summary of Market Movers Investor Summit
The 2026 Market Movers Investor Summit begins on May 4th with a kickoff party at the legendary Delmonico’s, followed by a full day of programming on May 5th. The summit brings together public and private company executives, fund managers, and family offices for a focused, high-caliber experience. The agenda includes company presentations and one-on-one meetings, exclusive fireside chats and keynote sessions, a pop-up lunch from the legendary Katz Delicatessen, and a surprise musical guest.
About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.
For more information, visit www.electrocore.com.
Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.